Correlation Between Edgewise Therapeutics and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Innate Pharma, you can compare the effects of market volatilities on Edgewise Therapeutics and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Innate Pharma.
Diversification Opportunities for Edgewise Therapeutics and Innate Pharma
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Innate is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Innate Pharma go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Innate Pharma
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.33 times more return on investment than Innate Pharma. However, Edgewise Therapeutics is 2.99 times less risky than Innate Pharma. It trades about -0.02 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.1 per unit of risk. If you would invest 3,357 in Edgewise Therapeutics on September 1, 2024 and sell it today you would lose (57.00) from holding Edgewise Therapeutics or give up 1.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Innate Pharma
Performance |
| Timeline |
| Edgewise Therapeutics |
| Innate Pharma |
Edgewise Therapeutics and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Innate Pharma
The main advantage of trading using opposite Edgewise Therapeutics and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx |
| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |